Mark R. Hake

Mark R. Hake

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

PayPal Is a Free Cash Flow Powerhouse Likely to Move a Good Deal Higher

PayPal is a free cash flow powerhouse likely to move a good deal higher. PayPal stock will continue to move higher as its FCF grows, active accounts increase and its total payment volume rises.

Wex Is Cheap and Will Rebound As Economic Transactions Rise

WEX stock is the kind of stalwart, cheap and enduring FCF-generating company you want to have in your portfolio over the long term.

Alteryx Eked Out a Profit, but That Doesn’t Make AYX Stock a Buy

Alteryx might eke out a profit this year, but it's still overvalued. AYX stock is too high at 257 times this year's earnings and 122 times next year, leaving it vulnerable to a steep drop.

Plug Power Is Still Losing Money Despite Its Goal

Plug Power is still losing money despite its goal of future EBITDA profits. Plug stock is not likely to do well until the company is consistently producing profits from hydrogen fuel sales.

NIO Stock Will Likely Tread Water Until Nio Is Profitable

NIO stock will tread water until Nio becomes profitable. Nio will survive. But for Nio to thrive it needs a path to profitability.

Abbott Labs Stock is Not Cheap But Should Do Well as Virus Test Debuts

Abbott Labs stock is not that cheap but should do well. Look for ABT stock to take off when its new 15-minute Covid-19 test is distributed and production ramps up

JFrog Is Another Highly Overvalued Recent Software Company IPO

JFrog is another highly overpriced recent software company IPO. FROG stock is likely to sell off once lock-up restrictions are lifted.

While Virgin Galactic Is Still a Speculative Play, It Could Move Higher

While Virgin Galactic is still a speculative play it could move higher. Even though SPCE stock is too expensive, analyst targets and options premiums imply it could move higher.

5 SPAC Stocks With Newly Announced Merger Deals and 2 Bonus Ideas

These five SPAC stocks have major merger deals that may be new, but most of them have a huge potential upside. So, let's take a look.

Disney Is Likely to Tread Water Until Next Year

Stay away from Disney stock as it's likely to tread water until next year. While Disney transitions from a venue focus to a content and streaming model, DIS stock may not rise by much.